Also listed on Spiracur Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 19, 2029 · High confidence
20-year base term ends Feb 17, 2029
Filed Apr 14, 2010 as application 12/760,406 · Granted Mar 6, 2012
Base term plus 183 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Feb 17, 2009
Feb 17, 2009
Term ends
Aug 19, 2029
Aug 19, 2029
Granted
Mar 6, 2012
Mar 6, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
183
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 183 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 17, 2009, when application 12/372,661, the earliest non-provisional in its chain, was filed (this one was filed Apr 14, 2010) | Feb 17, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +183 days, USPTO patent term adjustment record | Aug 19, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 19, 2029 | High confidence |
This family
| US 8,177,764 | In force Aug 2030 | Aug 2030 |
| US 8,128,607 | this patent Aug 2029 | Aug 2029 |
| US 8,337,474 | In force Dec 2029 | Dec 2029 |
| US 8,961,481 | In force Oct 2031 | Oct 2031 |
| US 9,283,307 | In force May 2032 | May 2032 |
| US 8,162,908 | In force Feb 2029 | Feb 2029 |
| US 8,926,575 | In force Dec 2029 | Dec 2029 |
| US 9,895,471 | Lapsed on the fee record Feb 2026 | Feb 2026 |
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 7, 2011 Reel 25751, frame 117 | Hu, Dean; Pinto, Moshe; Fong, Kenton | Spiracur Inc. | Assignment of Assignor's Interest |
| Oct 30, 2014 Reel 34076, frame 87 | Spiracur Inc., as Grantor | General Electric Capital Corporation, as Agent | Security Interest |
| Nov 14, 2015 Reel 37111, frame 836 | General Electric Capital Corporation, as Retiring Agent | Healthcare Financial Solutions, LLC, as Successor Agent | Assignment of Intellectual Property Security Agreement |
| Dec 1, 2015 Reel 37179, frame 541 | Healthcare Financial Solutions, LLC | Spiracur Inc. | Release of Security Interest |
| Dec 21, 2015 Reel 37355, frame 210 | Spiracur Inc. | KCI Licensing, Inc. | Assignment of Assignor's Interest |
| Sep 21, 2016 Reel 40098, frame 268 | KCI USA, Inc.; Lifecell Corporation; KCI Licensing, Inc. | Wilmington Trust, National Association, as Collateral Agent | Second Lien Security Agreement |
| Oct 7, 2016 Reel 40291, frame 237 | KCI USA, Inc.; Lifecell Corporation; KCI Licensing, Inc. | Wilmington Trust, National Association, as Collateral Agent | Limited Third Lien Intellectual Property Security Agreement |
| Feb 8, 2017 Reel 41666, frame 320 | Wilmington Trust | KCI USA, Inc. | Release of Security Interest Reel/Frame 040098/0268 |
| Nov 7, 2019 Reel 50966, frame 547 | Wilmington Trust, National Association | KCI USA, Inc.; KCI Licensing, Inc. | Release of Security Interest in Patents |
| Nov 7, 2019 reel/frame not recorded | Wilmington Trust, National Association | KCI USA, Inc. | Release of Security Interest in Patents |
| Nov 7, 2019 reel/frame not recorded | Wilmington Trust, National Association | KCI Licensing, Inc. | Release of Security Interest in Patents |
| Aug 28, 2023 Reel 64730, frame 636 | KCI Licensing, Inc. | 3M Innovative Properties Company | Assignment of Assignor's Interest |
| Feb 1, 2024 Reel 66436, frame 63 | 3M Innovative Properties Company | Solventum Intellectual Properties Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2029
Term ends Aug 19, 2029. No further fees fall due before then
Note
The 183 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
52
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.